ishikagovil.bsky.social
MIT ChemE PhD 👩🏻🔬 | Stark Lab
👤 Joined on 26 June 2025
Followers
Following
Total Posts
@ishikagovil.bsky.socialOut now: We present antibody-lectin chimeras (AbLecs) as a molecular platform to target sugars, or glycans, for cancer immunotherapy. www.nature.com/articles/s41... www.nature.com/articles/s41... @mitkochinstitute.bsky.social @mitdeptofbe.bsky.social @mitcheme.bsky.social @stanford-chemh.bsky.social
Show Post